Literature DB >> 6214715

Pulmonary hypoplasia in Down's syndrome.

T P Cooney, W M Thurlbeck.   

Abstract

We studied the lungs of seven patients of various ages who had Down's syndrome, to determine whether they had abnormalities in pulmonary development. Six of the seven had hypoplastic lungs. Five had congenital heart disease, but pulmonary hypoplasia was of equal severity, irrespective of the presence or absence or the type of congenital heart disease. Three other patients with congenital heart disease but without Down's syndrome had lungs that were equally diminished in volume. However, these lungs lacked the structural abnormalities seen in Down's syndrome, which consisted of a diminished number of alveoli in relation to acini and enlarged alveoli and alveolar ducts. The patients with Down's syndrome also had a smaller total number of alveoli and a smaller alveolar surface area. We speculate that the smaller alveolar surface area is accompanied by loss of capillary surface area, which is responsible for the aggravation of pulmonary hypertension in Down's syndrome.

Entities:  

Mesh:

Year:  1982        PMID: 6214715     DOI: 10.1056/NEJM198211043071902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

1.  Pulmonary hypoplasia.

Authors:  H J Porter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

2.  Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine.

Authors:  Clifford L Cua; Lynette K Rogers; Louis G Chicoine; Molly Augustine; Yi Jin; Patricia L Nash; Leif D Nelin
Journal:  Eur J Pediatr       Date:  2010-12-01       Impact factor: 3.183

Review 3.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

4.  Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates.

Authors:  C L Cua; A Blankenship; A L North; J Hayes; L D Nelin
Journal:  Pediatr Cardiol       Date:  2007-05-05       Impact factor: 1.655

5.  Earlier Pulmonary Valve Replacement in Down Syndrome Patients Following Tetralogy of Fallot Repair.

Authors:  Rachel T Sullivan; Peter C Frommelt; Garick D Hill
Journal:  Pediatr Cardiol       Date:  2017-06-14       Impact factor: 1.655

6.  Down's syndrome and the general practitioner.

Authors:  G Howells
Journal:  Occas Pap R Coll Gen Pract       Date:  1990-11

7.  Clinical features of paediatric pulmonary hypertension: a registry study.

Authors:  Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Journal:  Lancet       Date:  2012-01-11       Impact factor: 79.321

8.  A study to determine the prevalence of pulmonary arterial hypertension in children with Down syndrome and congenital heart disease.

Authors:  Mukti Sharma; Sanjeev Khera; Vishal Sondhi; Amit Devgan
Journal:  Med J Armed Forces India       Date:  2013-02-23

9.  Pulmonary changes in congenital heart disease with Down's syndrome: their significance as a cause of postoperative respiratory failure.

Authors:  S Yamaki; T Horiuchi; T Takahashi
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

10.  Congenital non-chylous pleural effusion with Down's syndrome.

Authors:  N Modi; R W Cooke
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.